Maharashtra FDA Takes Action: ₹34.51 Lakh in Drugs Seized
In a significant crackdown, the Maharashtra FDA has seized drugs and cosmetics worth ₹34.51 lakh and canceled 122 licenses.
The FDA conducted 1,986 inspections, leading to 674 notices issued.
Major seizures included ₹22.03 lakh worth of allopathic drugs in Nagpur.
Citizens are encouraged to report illegal drug activities to the FDA.
The Maharashtra Food and Drug Administration (FDA) has announced a major enforcement operation resulting in the seizure of drugs and cosmetics valued at ₹34.51 lakh. This action, which included the cancellation of 122 licenses and the suspension of 422 others, was reported in a press release on November 5, 2026, following extensive inspections throughout October.
During October, the FDA conducted a total of 1,986 inspections across various drug manufacturing and sales establishments. Out of these, 1,694 were focused on drug sales, while 292 targeted manufacturing and other regulated entities. The inspections led to the issuance of 674 notices, highlighting the department's commitment to ensuring compliance with safety regulations.
Among the notable incidents, FDA officials recovered allopathic drugs worth ₹22.03 lakh from Phoenix Medicorp in Nagpur on October 7. This establishment was found to be storing drugs at unlicensed premises, despite having surrendered its licenses. Additionally, in Mumbai, spurious drugs valued at ₹1.01 lakh were seized from INHS Asvini in Colaba on October 29, further emphasizing the ongoing issue of counterfeit medications.
The FDA's operations also included significant seizures in Chhatrapati Sambhajinagar, where 199 Nitrosun 10 tablets containing Nitrazepam were confiscated, leading to the arrest of four individuals for their involvement in illegal sales. Furthermore, cosmetic products worth ₹4.05 lakh were seized from Vedas Herbals Mahila Gruh Udyog in Pune for alleged unlicensed manufacturing.
Looking ahead, the FDA has conducted a total of 7,950 inspections from April 1 to October 31, resulting in 2,888 notices, 555 license cancellations, and 2,074 suspensions. The department has urged the public to report any illegal drug manufacturing or sales activities to their local offices, reinforcing their proactive approach to safeguarding public health.
